Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study

About this Attention Score

• In the top 25% of all research outputs scored by Altmetric
• High Attention Score compared to outputs of the same age (92nd percentile)
• Good Attention Score compared to outputs of the same age and source (66th percentile)